The development of surface-enhanced Raman scattering as a detection modality for portable in vitro diagnostics: progress and challenges

2013 ◽  
Vol 15 (47) ◽  
pp. 20415 ◽  
Author(s):  
Ashley J. Driscoll ◽  
Mark H. Harpster ◽  
Patrick A. Johnson
Biosensors ◽  
2021 ◽  
Vol 11 (11) ◽  
pp. 449
Author(s):  
Francesco Dell’Olio

The recent improvements in diagnosis enabled by advances in liquid biopsy and oncological imaging significantly better cancer care. Both these complementary approaches, which are used for early tumor detection, characterization, and monitoring, can benefit from applying techniques based on surface-enhanced Raman scattering (SERS). With a detection sensitivity at the single-molecule level, SERS spectroscopy is widely used in cell and molecular biology, and its capability for the in vitro detection of several types of cancer biomarkers is well established. In the last few years, several intriguing SERS applications have emerged, including in vivo imaging for tumor targeting and the monitoring of drug release. In this paper, selected recent developments and trends in SERS applications in the field of liquid biopsy and tumor imaging are critically reviewed, with a special emphasis on results that demonstrate the clinical utility of SERS.


RSC Advances ◽  
2016 ◽  
Vol 6 (64) ◽  
pp. 58943-58949 ◽  
Author(s):  
Debraj Gangopadhyay ◽  
Poornima Sharma ◽  
Sachin Kumar Singh ◽  
Pushkar Singh ◽  
Volker Deckert ◽  
...  

Raman signatures of decyclization of creatinine to creatine appear after 120 min at pH 8, 60 min at pH 10 and 30 min at pH 12. Signature of reversibility at later stages of the reaction.


RSC Advances ◽  
2016 ◽  
Vol 6 (113) ◽  
pp. 112562-112567 ◽  
Author(s):  
Debraj Gangopadhyay ◽  
Poornima Sharma ◽  
Rajib Nandi ◽  
Moumita Das ◽  
Surajit Ghosh ◽  
...  

(a) SERS spectra and (b) fluorescence spectra of Jaffe complex showing consistent variation relatable to the concentration of CRN.


2014 ◽  
Vol 613 ◽  
pp. 127-132 ◽  
Author(s):  
Poornima Sharma ◽  
Debraj Gangopadhyay ◽  
Pushkar Singh ◽  
P.C. Mishra ◽  
Volker Deckert ◽  
...  

2018 ◽  
Vol 25 (35) ◽  
pp. 4638-4652 ◽  
Author(s):  
Dionysia Tsoutsi ◽  
Marcos Sanles-Sobrido ◽  
Andreu Cabot ◽  
Pilar-Rivera Gil

This review overviews the impact in biomedicine of surface enhanced. Raman scattering motivated by the great potential we believe this technique has. We present the advantages and limitations of this technique relevant to bioanalysis in vitro and in vivo and how this technique goes beyond the state of the art of traditional analytical, labelling and healthcare diagnostic technologies.


Biosensors ◽  
2021 ◽  
Vol 11 (2) ◽  
pp. 54
Author(s):  
Cheng-Ju Sung ◽  
Szu-Han Chao ◽  
Shih-Chieh Hsu

In this report, we summarized our development of biosensors for Rhodamine 6G and in vitro glucose detection based on surface-enhanced Raman scattering technology. For the detection of both Rhodamine 6G and in vitro glucose, a nature-patterned substrate with gold films over nanostructures (NPS-AuFON) was used as the surface-enhanced Raman scattering sensor platform. The enhancement factor was calculated at 9 × 107. In the processing of the substrate, cyclic voltammetry was used to form nano-gold particles under different conditions. The Rhodamine 6G and glucose detection were then achieved on this substrate. Furthermore, we combined the potentiostatic technique and electrochemical adsorption to best detect glucose in low concentrations. The glucose oxidation potential (100 mV) was used to capture glucose close to the surface of the NPS-AuFON. The quantitative detection of glucose in solution and in situ inspection were confirmed. Further, we determined that this surface modification technology can reach the goal of experiments set by the World Health Organization to judge whether or not a patient is a diabetic by detecting a glucose concentration of 11.1 mmol/L (mg/dL) at a minimum.


Sign in / Sign up

Export Citation Format

Share Document